especially<\/em> pharma, prides itself on being inflation proof. I am hardly alone in that opinion.<\/p>\nBetween October 26, 2022 and November 23, 2022, a major survey was done by Global Data Healthcare of pharma executives. They listed their most important concerns in the following order: \u201cinflation first<\/em>, drug pricing<\/em> and reimbursement constraints second<\/em>, the Ukraine conflict third and the political divide in the United States fourth.\u201d<\/p>\nInflation is an important concern and. of course, price increases and reimbursement limits. The survey also states:<\/p>\n
\u201cThe [survey] firm noted that the industry will need to navigate \u2018financial and strategic risks.\u2019\u00a0Pharma companies \u2018will\u00a0need to find new ways to offset regulatory and inflationary pressures.\u2019\u201d<\/p>\n
The message is clear<\/strong><\/p>\nThough the media may talk of the pharmaceutical industry as being recession-proof, everyone in the industry realizes it isn\u2019t. Inflation is the number one concern, though it seems like no one wants to talk about it. In an industry sensitive to what \u201cothers\u201d say about its pricing, there isn\u2019t an incentive to discuss why prices increase.<\/p>\n
The pharmaceutical industry is under the same pressures as any other manufacturing industry \u2013 and then some. The need to research, develop and innovate; the need to streamline, digitize and improve systems; the challenges posed by supply chains, insurance, politics and the general public are enormous. All of it, even the need to constantly publicize leads to spiraling prices. It is no, \u201cone thing,\u201d but everything.<\/p>\n
The issue is how pharma sales teams, as part of the industry, will respond to the challenges. There is much more at stake than remaining silent or issuing \u201capologies.\u201d Patients need<\/em> what the industry offers. Lifesaving or life enhancing medications aren\u2019t like consumer products. They shouldn\u2019t be ignored in an inflationary cycle, or dosages cut and skipped because other items take priority. However, someone must make a difference in how treatments are viewed. The difference-maker is you<\/em>.<\/p>\nThere might be \u201c100 points of resistance,\u201d but it is up to each pharma sales rep to have the attitude, the mindset<\/em> to communicate and educate, to offer service above and beyond and to outlearn the competition. To do so, is to view your role as an educator and communicator. If you believe in what you\u2019re selling, then help the customer see it, understand it and support it.<\/p>\nThis mindset requires you to embrace the purpose and the potential of what your company is offering.<\/p>\n
In the end, it comes down to determination<\/em>. If there is no resolve to help customers see what you see, then fears of inflation will<\/em> replace the health fears of ignoring the qualities that make the drug important.<\/p>\nIn the end, \u201cinflation,\u201d the one thing no one wants to talk about, can never be made as important as the benefit of what you offer.<\/p>\n
<\/p>\n
<\/p>\n
To reach Scott Burrows, Motivational Pharma Sales Speaker<\/a>, contact Scott today by phone at: 520 \u2013 548 \u2013 1169 or through this website.<\/p>\n <\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
The One Thing No One Wants to Talk About It is about time we talked about the \u201cI-word,\u201d or inflation, for as a pharma motivational sales speaker and pharma sales consultant, it concerns me when any industry, especially pharma, prides itself on being inflation proof. I am hardly alone in that opinion. Between […]<\/p>\n","protected":false},"author":1,"featured_media":11989,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","footnotes":""},"categories":[10,11,13,156,15,16,17,19,21,23,25,26,29,30,32,35,36,38,40,42,43],"tags":[9,12,14,157,18,20,22,24,27,28,31,33,34,37,39,41],"yoast_head":"\n
Scott Burrows, Motivational Pharma Sales Speaker - Scott Burrows<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\t\n\t\n\t\n